Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1978 Mar;5(3):227–231. doi: 10.1111/j.1365-2125.1978.tb01629.x

Outcome of pregnancy in mothers given bromocriptine.

R W Griffith, I Turkalj, P Braun
PMCID: PMC1429261  PMID: 656267

Abstract

1 Information has been obtained on the outcome of 448 completed pregnancies in mothers who had been given bromocriptine at some stage in the early weeks of pregnancy. 2 The frequencies of spontaneous abortions, twin pregnancies and malformations have been compared with those reported for 'normal' populations. 3 Based on this limited material, we conclude that the use of bromocriptine to restore fertility in hyperprolactinaemic women is not associated with an increased risk of abortion, multiple pregnancy or the occurrence of malformations in the infants.

Full text

PDF
227

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahlgren M., Källén B., Rannevik G. Outcome of pregnancy after clomiphene therapy. Acta Obstet Gynecol Scand. 1976;55(4):371–375. doi: 10.3109/00016347609158516. [DOI] [PubMed] [Google Scholar]
  2. Franks S., Jacobs H. S., Hull M. G., Steele S. J., Nabarro J. D. Management of hyperprolactinaemic amenorrhoea. Br J Obstet Gynaecol. 1977 Apr;84(4):241–253. doi: 10.1111/j.1471-0528.1977.tb12571.x. [DOI] [PubMed] [Google Scholar]
  3. Hack M., Brish M., Serr D. M., Insler V., Lunenfeld B. Outcome of pregnancy after induced ovulation. Follow-up of pregnancies and children born after gonadotropin therapy. JAMA. 1970 Feb 2;211(5):791–797. [PubMed] [Google Scholar]
  4. Jürgensen O., Taubert H. D. Cervical incompetence and premature delivery after bromocriptine therapy for infertility. Lancet. 1977 Jul 23;2(8030):203–204. doi: 10.1016/s0140-6736(77)90229-x. [DOI] [PubMed] [Google Scholar]
  5. Kase N. Induction of ovulation with clompiphene citrate. Clin Obstet Gynecol. 1973 Sep;16(3):192–200. doi: 10.1097/00003081-197309000-00013. [DOI] [PubMed] [Google Scholar]
  6. Smithells R. W. Environmental teratogens of man. Br Med Bull. 1976 Jan;32(1):27–33. doi: 10.1093/oxfordjournals.bmb.a071319. [DOI] [PubMed] [Google Scholar]
  7. Spadoni L. R., Cox D. W., Smith D. C. Use of human menopausal gonadotropin for the induction of ovulation. Am J Obstet Gynecol. 1974 Dec 1;120(7):988–993. doi: 10.1016/0002-9378(74)90352-4. [DOI] [PubMed] [Google Scholar]
  8. Thompson C. R., Hansen L. M. Pergonal (menotropins): a summary of clinical experience in the induction of ovulation and pregnancy. Fertil Steril. 1970 Dec;21(12):844–853. doi: 10.1016/s0015-0282(16)37925-0. [DOI] [PubMed] [Google Scholar]
  9. Thorner M. O., Besser G. M., Jones A., Dacie J., Jones A. E. Bromocriptine treatment of female infertility: report of 13 pregnancies. Br Med J. 1975 Dec 20;4(5998):694–697. doi: 10.1136/bmj.4.5998.694. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES